Literature DB >> 20143331

Transdifferentiation potentiality of human Wharton's jelly stem cells towards vascular endothelial cells.

Miguel Alaminos1, Bárbara Pérez-Köhler, Ingrid Garzón, Natalio García-Honduvilla, Beatriz Romero, Antonio Campos, Julia Buján.   

Abstract

Human Wharton's jelly stem cells (HWJSC) emerged as a potential source of viable cells for use in tissue engineering. In this work, we have analyzed the transdifferentiation capabilities of HWJSC towards transdifferentiated endothelial-like cells (Tr-ELC) in order to establish the potential usefulness of these cells in vascular tissue engineering. Our results show that Tr-ELC became more polygonal and less proliferative than HWJSC, resembling the structure and proliferation rate of the endothelial cells. In addition, the markers of mesenchymal undifferentiation CD9, E-cad, PODXL, and SSEA-4 are downregulated in Tr-ELC, suggesting that these cells can be in the process of adult differentiation. Besides, RT-PCR and microarray analyses revealed that some genes with a role in defining the endothelial phenotype and structure are upregulated (VEGF-R1, EDF1, AAMP, CD31, CD34, CDH5, and ICAM2) or downregulated (VEGF) in Tr-ELC, although a number of genes related to relevant endothelial cell functions (CD36, ECE2, VWF, THBD, PGI2, ECE1, and ACE) did not change or were only partially induced. All this implies that HWJSC are able to efficiently transdifferentiate towards Tr-ELC at the phenotypical level following a hierarchical pattern of gene activation, with an earlier induction of morphological and phenotypical genes. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20143331     DOI: 10.1002/jcp.22062

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

1.  Evaluation of the cell viability of human Wharton's jelly stem cells for use in cell therapy.

Authors:  Ingrid Garzón; Barbara Pérez-Köhler; Juan Garrido-Gómez; Victor Carriel; Renato Nieto-Aguilar; Miguel Angel Martín-Piedra; Natalio García-Honduvilla; Julia Buján; Antonio Campos; Miguel Alaminos
Journal:  Tissue Eng Part C Methods       Date:  2012-01-26       Impact factor: 3.056

Review 2.  Umbilical cord-derived mesenchymal stem cells: strategies, challenges, and potential for cutaneous regeneration.

Authors:  Siming Yang; Sha Huang; Changjiang Feng; Xiaobing Fu
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

Review 3.  Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues.

Authors:  Hassan Abdulrazzak; Dafni Moschidou; Gemma Jones; Pascale V Guillot
Journal:  J R Soc Interface       Date:  2010-08-25       Impact factor: 4.118

4.  ROCK inhibitor Y-27632 increases thaw-survival rates and preserves stemness and differentiation potential of human Wharton's jelly stem cells after cryopreservation.

Authors:  Kalamegam Gauthaman; Chui-Yee Fong; Arjunan Subramanian; Arijit Biswas; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

5.  Wharton's jelly stem cells: a novel cell source for oral mucosa and skin epithelia regeneration.

Authors:  Ingrid Garzón; Juliano Miyake; Miguel González-Andrades; Ramón Carmona; Carmen Carda; María del Carmen Sánchez-Quevedo; Antonio Campos; Miguel Alaminos
Journal:  Stem Cells Transl Med       Date:  2013-07-01       Impact factor: 6.940

Review 6.  The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine.

Authors:  N Forraz; C P McGuckin
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 7.  Stem Cells as a Promising Tool for the Restoration of Brain Neurovascular Unit and Angiogenic Orientation.

Authors:  Mohammad Hossein Geranmayeh; Alireza Nourazarian; Çığır Biray Avci; Reza Rahbarghazi; Mehdi Farhoudi
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

8.  Improving the attachment and proliferation of umbilical cord mesenchymal stem cells on modified polystyrene by nitrogen-containing plasma.

Authors:  Somruthai Tunma; Kewalin Inthanon; Chanokporn Chaiwong; Jantrawan Pumchusak; Weerah Wongkham; Dheerawan Boonyawan
Journal:  Cytotechnology       Date:  2012-07-04       Impact factor: 2.058

9.  Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells.

Authors:  Chui-Yee Fong; Li-Ling Chak; Arijit Biswas; Jee-Hian Tan; Kalamegam Gauthaman; Woon-Khiong Chan; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 10.  Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?

Authors:  Fábio G Teixeira; Miguel M Carvalho; Nuno Sousa; António J Salgado
Journal:  Cell Mol Life Sci       Date:  2013-03-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.